Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa

NCT01468207 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

307

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa (HS)

Interventions

BIOLOGICAL: adalimumab
BIOLOGICAL: placebo

Sponsor

AbbVie (prior sponsor, Abbott)